Injectable Therapies in Diabetes
|
|
- Leonard Baldwin
- 5 years ago
- Views:
Transcription
1 Injectable Therapies in Diabetes Diabetes Specialist Nurse Linda Burns
2 Learning Outcomes Understand the place of injectible therapies in diabetes Understand when patients may require insulin therapy Consider insulin profiles and regimes Understand when patients may require GLP1 inhibitors Safe practice and injectible therapies in diabetes
3 When injectibles therapies are used in diabetes? Type 1 diabetes 1 st line no alternative to insulin lack of insulin leads to burning of body fats and ketone production >?DKA Type 2 diabetes - insulin resistance loss of insulin effectiveness poor response to oral agents. Injectibles then required- Variable time line. May require insulin or Glucagon Like Peptides 1receptors agonists (GLP-1s) by injection
4 Daily Requirements Normal Daily Insulin Profiles Breakfast Lunch Evening Meal Blood sugar Mealtime insulin Background insulin required for basal metabolic requirements For regular eating pattern you require a background of insulin and three bolus doses of insulin. This happens in health with no diabetes.
5 Common insulin regimes for Match insulin profile to the needs of individual patients and follow GGC guidelines Once daily intermediate or long acting background insulins eg. Humulin I, Insulatard, Insuman basal, Levemir, Lantus May be used in combination with oral hypoglycaemic agents Twice daily mixed insulin e.g. HumulinI, Novomix 30, Insuman Comb 50 may be used - if not achieving adequate glycaemic control on once daily regime
6 Common Insulin regimes cont. Three times daily mixed insulin eg. Humalog Mix 50, Insuman Comb 50 If patient is highly insulin resistant Multiple dose injections /basal bolus eg. Lantus or Levemir plus Novorapid or Humalog Insulin Pumps Constant infusion of rapid acting insulin
7 Types of insulin: short acting (clear) rapid acting (clear). intermediate (cloudy). Fixed (bi phasic) mixtures - combination of short and medium insulin (cloudy) e.g Longer acting insulin analogues (clear) e.g.. New insulins 300iu strength Types of Insulin?
8
9 Insulin Patients with T2DM who have concurrent problems, may require insulin urgently for example... Steroid therapy Acute infection Pre or post surgery Gestational diabetes Type 2 diabetes in pregnancy
10 Insulin therapy getting it right... Injection technique / timing /compliance Carbohydrates Avoiding and treating hypos appropriately Self managing where possible morning insulin lunch / tea time results evening insulin supper / breakfast results Stable blood sugars improved outcomes
11 Getting it wrong... Delivery devices Withdrawing insulin from pen devices Sharps disposal Insulin prescriptions Communication pathways Patients fasting
12
13 Injectable Therapies - GLP1 GLP-1 - Incretin gut hormone Used only in Type 2 diabetes 3 rd line medication although can be used earlier in treatment algorithm Useful if insulin needs to be avoided eg taxi drivers, HGV drivers
14 GLP1 how do they work? Increases insulin production when blood glucose levels are high. Reduces insulin production when blood glucose levels are low...results in No hypos unless on another agent for example gliclazide Slows down speed of stomach emptying reduce appetite *****weight loss*****
15 GLP1 currently in use exenatide (Byetta) twice daily injection exenatide (Bydureon) once weekly injection lixisenatide (Lyxumia) Once daily injection. liraglutide (Victoza) once daily injection dulaglutide (Trulicity) Once weekly injections Degludec/liraglutide (Xultophy) once daily insulin/glp1 mixture
16 side effects of GLP1 Nausea and GI upset can occur on initiation of treatment but usually settles Rare side effect of pancreatits Reduction of appetite Weight loss
17 Injection technique for insulin and GLP1 agents DSN support initially towards patient self managing Use of Injection prompt sheets Expel 2units prior to injection Why? Size 4 or 5mm needles now - no need to pinch 90 degree angle Rotate sites / Why? Encourage patients not to resheath or -reuse needles
18 Good injection techniques If DN dependent syringe/needle if available in vial form, to minimise risk of needlestick injuries. If required to use a pen device encourage patient to remove needle, or use a BD safe clip Observe GGC policy Administration of Insulin by Injection and Blood Glucose Monitoring, District Nursing
19 Further Learning 5 Modules available on Learn Pro Contact diabetes team if any concerns or need advice
20 Any Questions??? Thank you
21 Thank you
Injectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Joyce Robson Learning Outcomes Think about the place of injectible therapies in diabetes Think about when / why patients require insulin therapy
More informationInjectable Therapies in Diabetes
Injectable Therapies in Diabetes Diabetes Specialist Nurse Joyce Robson Learning Outcomes Think about the place of injectible therapies in diabetes Insulin therapy GLP1 antagonists Consider commonly used
More informationInformation for Patients
Information for Patients Guidance for Diabetic Persons having an OGD or Bronchoscopy This guidance is provided to assist with your preparation for your endoscopic procedure. If you feel unclear about how
More informationInitiating Injectables in Type 2 Diabetes. Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital
Initiating Injectables in Type 2 Diabetes Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital Increasing levels in delivery of diabetes care Complex Care support 3 3.1 People with diabetes
More informationThe principles of insulin adjustment guidance
The principles of insulin adjustment guidance Tips for insulin titration Blood glucose (BG) monitoring is needed to help identify the efficacy of treatment in diabetes. Monitor blood glucose according
More informationHow they work and when to take them. Diabetes Medications
How they work and when to take them Diabetes Medications BIGUANIDES Metformin Actions Slows down the release of glucose from the liver. Helps the bodies cells become more sensitive to insulin. Pros Weight
More informationKEEPING SAFE WITH INSULIN THERAPY
KEEPING SAFE WITH INSULIN THERAPY kk WHY IS THIS LEAFLET FOR YOU? Insulin treatment improves the quality of life in many people and saves the lives of others. It is used to lower blood glucose levels.
More informationWhat the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin
Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team
More informationInsulin Management. By Susan Henry Diabetes Specialist Nurse
Insulin Management By Susan Henry Diabetes Specialist Nurse The Discovery of Insulin - 1921 - Banting & Best University Of Toronto Discovered hormone insulin in pancreatic extract of dog - Marjorie the
More informationThere have been important changes in diabetes care which may not be covered in undergraduate textbooks.
Diabetes Clinical update There have been important changes in diabetes care which may not be covered in undergraduate textbooks. Changes in the diagnosis of diabetes a) HbA1C Since 2011, World Health Organisation
More informationTREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse
TREATMENTS FOR TYPE 2 DIABETES Susan Henry Diabetes Specialist Nurse How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management
More informationShort-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins
Recommended Insulin Products This guideline states the Gloucestershire Joint Formulary recommended, first choice insulin products. The intention is to support the choice of treatment for new patients,
More informationTYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS
TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS The aim of the Diabetes level 2 service is to provide a high quality service for safe initiation and optimization of injectable therapy within GP networks.
More informationINJECTABLE THERAPY FOR THE TREATMENT OF DIABETES
INJECTABLE THERAPY FOR THE TREATMENT OF DIABETES ARSHNA SANGHRAJKA DIABETES SPECIALIST PRESCRIBING PHARMACIST OBJECTIVES EXPLORE THE TYPES OF INSULIN AND INJECTABLE DIABETES TREATMENTS AND DEVICES AVAILABLE
More informationEnd of Life Diabetes Care
End of Life Diabetes Care Commissioned by Diabetes UK Supplementary Documents and Flowcharts Endorsed By: Diabetes Phases of End of Life and Medications A - Blue: All From Diagnosis Stable With Year Plus
More informationFasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period
Fasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period Dr Ketan Dhatariya MBBS MSc MD MS FRCP Consultant in Diabetes and Endocrinology Norfolk and Norwich
More informationManaging diabetes if you are having a colonoscopy
Managing diabetes if you are having a colonoscopy Diabetes and Endocrinology Patient Information Leaflet Introduction This leaflet provides advice and instructions to people with diabetes who are going
More informationGLP-1 Receptor Agonists and SGLT-2 Inhibitors. Debbie Hicks
GLP-1 Receptor Agonists and SGLT-2 Inhibitors Debbie Hicks Prescribing and Adverse Event reporting information is available at this meeting from the AstraZeneca representative The views expressed by the
More informationDiabetes, Type 2 Management
CLINICAL GUIDELINE Diabetes, Type 2 Management A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised on the applicability
More informationDrugs used in Diabetes. Dr Andrew Smith
Drugs used in Diabetes Dr Andrew Smith Plan Introduction Insulin Sensitising Drugs: Metformin Glitazones Insulin Secretagogues: Sulphonylureas Meglitinides Others: Acarbose Incretins Amylin Analogues Damaglifozin
More informationObjectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)
How Medicine Works to Control Blood Sugar Levels Stacie Petersen, RN, CDE Objectives Define Diabetes List how medications work (ominous octet) Identify side effects of medications for diabetes What is
More informationGLP-1 receptor agonists for type 2 diabetes currently available in the U.S.
GLP-1 receptor agonists for type 2 diabetes currently available in the U.S. GLP-1 agonists are a class of antidiabetic agents that mimic the actions of the glucagon-like peptide. GLP-1 is one of several
More informationPeri-operative management of the surgical patient with diabetes GL059
DT Peri-operative management of the surgical patient with diabetes GL059 Approval Approval Group Job Title, Chair of Committee Date Anaesthetics Clinical Governance Chair Anaesthetic governance Nov 2016
More informationINJECTABLE THERAPIES IN DIABETES. Barbara Ann McKee Diabetes Specialist Nurse
INJECTABLE THERAPIES IN DIABETES Barbara Ann McKee Diabetes Specialist Nurse 1 Aims of the session Describe the different injectable agents for diabetes and when they would be used. Describe some common
More informationBEST 4 Diabetes. Optimisation of insulin module
BEST 4 Diabetes Optimisation of insulin module Confidence and competence Where would you rate yourself? Why do all of our patient not achieve optimal blood glucose control? Insulin Therapy Goals and Purpose
More informationEFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY
Specialist details Patient identifier Name Tel: EFFECTIVE SHARE CARE AGREEMENT FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY The aim of Effective Shared Care Guidelines
More informationOxford Kidney Unit. Preparing for your operation: information for people with chronic kidney disease
Oxford Kidney Unit Preparing for your operation: information for people with chronic kidney disease page 2 You have been given this booklet to help you prepare for a surgical procedure under general anaesthetic.
More informationHow can we improve outcomes in Type 2 diabetes?
How can we improve outcomes in Type 2 diabetes? Earlier diagnosis Better patient education Stress central role of lifestyle management Identify and treat all risk factors Use rational pharmacological therapy
More informationErtugliflozin (Steglatro ) 5 mg daily. May increase to 15 mg daily. Take in the morning +/- food. < 60: Do not initiate; discontinue therapy
Sodium-glucose Cotransporter-2 (SGLT2) s Inhibit SGLT in proximal renal tubules, reducing reabsorption of filtered glucose from tubular lumen Lowers renal threshold for glucose à increase urinary excretion
More informationGLP-1 agonists. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK
GLP-1 agonists Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK What do GLP-1 agonists do? Physiology of postprandial glucose regulation Meal ❶ ❷ Insulin Rising plasma
More informationFARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)
Type 2 Medications Drug Class How It Works Brand and Generic Names Manufacturers Usual Starting Dose The kidneys filter sugar and either absorb it back into your body for energy or remove it through your
More informationA patient guide to the use of insulin for diabetes
A patient guide to the use of insulin for diabetes Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationBEST 4 Diabetes. Optimisation of insulin module
BEST 4 Diabetes Optimisation of insulin module Confidence and competence Where would you rate yourself? Why do all of our patient not achieve optimal blood glucose control? Insulin Therapy Goals and Purpose
More informationClinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures
Clinical Guidelines Management of adult patients with diabetes undergoing endoscopic s Document Detail Document type Clinical Guideline Management of adult Patients with diabetes Undergoing Document name
More informationTHIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN
Worcestershire Trusts Please attach patient sticker here or record: GP Name: Consultant:. Ward: THIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN This Care Pathway
More informationTitle Peri-operative Guidelines for the Management of Patients with Diabetes. Author s job title Diabetes Specialist Nurse Department.
Patients with Document Control Title Peri-operative Guidelines for the Management of Patients with Author Directorate Medicine Version Date Issued 0.1 Jan 2011 Status Draft Initial version Author s job
More informationUpdated August /08/2020
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Directorate & Speciality Guideline for the management of adults with diabetes
More informationDept of Diabetes Main Desk
Dept of Diabetes Main Desk 01202 448060 Glucose management in Type 2 Diabetes in Adults The natural history of type 2 diabetes is for HbA1c to deteriorate with time. A stepwise approach to treatment is
More informationWhat do you need to know before you go home?
What do you need to know before you go home? What is Insulin Types of Insulin Injection Sites How to Inject Insulin Correctly Low Blood Sugar and Treatment Sick Day Management After leaving the Hospital:
More informationHypoglyceamia and Exercise
Hypoglyceamia and Exercise Noreen Barker Diabetes Specialist Nurse May 2016 Hypoglyceamia What is a hypo? Why are we concerned? Signs and symptoms Treatments Causes Hypo unawareness Managing diabetes and
More informationLeicestershire Diabetes Guidelines: Insulin Therapy
Endorsed by Leicestershire Medicines Strategy Group Leicestershire Diabetes Guidelines: Insulin Therapy These guidelines are designed for use by those trained and competent in insulin initiation and management
More informationInsulin Safety. Tracey Roe DSN SSOT partnership trust
Insulin Safety Tracey Roe DSN SSOT partnership trust Insulin Type 1 Type 2 when oral therapies are not tolerated or contra/indicated Post MI Intercurrent illness Pre/peri/post op Gestational diabetes Painful
More informationPeri-Operative Guidelines for Management of Diabetes Patients
Peri-Operative Guidelines for Management of Diabetes Patients Target blood glucose 6-10 mmol/l for all patients Acceptable blood glucose 4-11 mmol/l for all patients Definitions Non-Insulin Glucose Lowering
More informationStarting Insulin in General Practice
Starting Insulin in General Practice Timothy Kenealy GP & Assoc Prof of Integrated Care, University of Auckland Auckland DHB / my version + Counties DHB version Starting Insulin surprisingly simple, safe
More informationDIABETES INDICATIONS FOR INSULIN
DIABETES INDICATIONS FOR INSULIN 1 Introduce the likely need for insulin in the future early on as part of patient education Emphasise that it is the pancreas that fails not the patient Assess if greater
More informationSTEP THERAPY CRITERIA
CATEGORY DRUG CLASS BRAND NAME (generic) STEP THERAPY CRITERIA AMYLIN ANALOG: SYMLIN/SYMLINPEN (pramlintide acetate) ANTIDIABETIC AGENTS GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST (GLP-1): ADLYXIN (lixisenatide)
More informationBEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)
BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC) Overarching Shared Care Guideline for Glucagon-like peptide 1 (GLP 1) agonists, February 2017. PATIENT S NAME: PATIENT S ADDRESS: HOSPITAL NAME
More informationIncredible Incretins Abby Frye, PharmD, BCACP
Incredible Incretins Abby Frye, PharmD, BCACP Objectives & Disclosures Review the pathophysiology of T2DM and the impact of the incretin system Describe the defining characteristics of the available glucagonlike
More informationPERIOPERATIVE DIABETES GUIDELINE
PERIOPERATIVE DIABETES GUIDELINE This Guideline does not replace the need for the application of clinical judgment in respect to each individual patient. Background Diabetes mellitus is estimated to affect
More informationInsulin Initiation and Intensification. Disclosure. Objectives
Insulin Initiation and Intensification Neil Skolnik, M.D. Associate Director Family Medicine Residency Program Abington Memorial Hospital Professor of Family and Community Medicine Temple University School
More informationPump Failure Guidelines
Pump Failure Guidelines Planning Ahead All technology, including pumps, can fail occasionally, even within their warranty period. It is important to be able to independently initiate injection treatment
More informationManaging Diabetes when you are having a colonoscopy
Managing Diabetes when you are having a colonoscopy Disclaimer This is general information developed by The Ottawa Hospital. It is not intended to replace the advice of a qualified health-care provider.
More informationDiabetes, Ketone testing in Type 1 Diabetes
CLINICAL GUIDELINE Diabetes, Ketone testing in Type 1 Diabetes A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. Clinical judgement should be exercised
More informationTips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital
Tips and Tricks for Starting and Adjusting Insulin MC MacSween The Moncton Hospital Progression of type 2 diabetes Beta cell apoptosis Natural History of Type 2 Diabetes The Burden of Treatment Failure
More informationTABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations
177 TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations Formulary Coverage Indication for use with: INSULIN THERAPY NS NB NL PE ADULTS PEDIATRICS PREGNANCY BOLUS
More informationUniversity Hospitals of Leicester NHS Trust. Carbohydrates. A guide to carbohydrate containing foods for people with diabetes
University Hospitals of Leicester NHS Trust Carbohydrates A guide to carbohydrate containing foods for people with diabetes A Healthy Diet This information is designed to help you to understand how carbohydrates
More informationManaging Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines
Document Control Title Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Author Author s job title Specialist Nurse Consultant Physician Department Directorate Unscheduled Care Version Date
More informationThe main symptoms come on over a period of weeks and are:
1 Type 1 Diabetes What c auses t ype 1 d iabetes? Diabetes is a disorder in which blood glucose levels are high. In normal health, blood glucose levels are precisely controlled by the hormone insulin.
More informationInsulin Therapies: An Educational Toolkit
University Hospitals of Leicester, Department of Diabetes and Leicester Diabetes Centre: Insulin Therapies: An Educational Toolkit This document is designed for use by those trained and competent in insulin
More informationDIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013
DIABETES Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes November 2013 mbruskewitz@outlook.com Objectives Part 1 Overview of Endocrine Physiology Pathophysiology of Diabetes Diabetes
More informationDR HJ BODANSKY MD FRCP CONSULTANT PHYSICIAN LEEDS TEACHING HOSPITALS ASSOCIATE PROFESSOR, UNIVERSITY OF LEEDS
DR HJ BODANSKY MD FRCP CONSULTANT PHYSICIAN LEEDS TEACHING HOSPITALS ASSOCIATE PROFESSOR, UNIVERSITY OF LEEDS DIABETETES UPDATE 2015 AIMS OF THE SEMINAR Diagnosis Investigation Management When to refer
More informationGLP-1 RECEPTOR AGONIST SHOULD I TRY IT? VERONICA BRADY, PHD, BC-ADM, CDE PROJECT ECHO JUNE 21, 2018
GLP-1 RECEPTOR AGONIST SHOULD I TRY IT? VERONICA BRADY, PHD, BC-ADM, CDE PROJECT ECHO JUNE 21, 2018 SOMETHING TO CONSIDER IF YOU COULD PRESCRIBE A MEDICATION FOR YOUR PATIENT WITH DIABETES THAT: DECREASED
More informationTypes of insulin. Your blood glucose levels. Types of insulin
Different types of insulin are available for people with diabetes. If you need insulin, you and your diabetes team will look at the options and decide which type fits best with your lifestyle and blood
More informationCase Study: Competitive exercise
Case Study: Competitive exercise 32 year-old cyclist Type 1 diabetes since age 15 Last HbA1 54 No complications and hypo aware On Humalog 8/8/8 and Levemir 15 Complains about significant hypoglycaemia
More informationAdjusting Your Diabetes Medicine and Diet for a Test or Procedure
health information Adjusting Your Diabetes Medicine and Diet for a Test or Procedure The guidelines below will help you adjust your diabetes medicine and diet as you get ready for your procedure or lab
More informationGLP-1 (glucagon-like peptide-1) Agonists (Byetta, Bydureon, Tanzeum, Trulicity, Victoza ) Step Therapy and Quantity Limit Criteria Program Summary
OBJECTIVE The intent of the GLP-1 (glucagon-like peptide-1) s (Byetta/exenatide, Bydureon/ exenatide extended-release, Tanzeum/albiglutide, Trulicity/dulaglutide, and Victoza/liraglutide) Step Therapy
More informationSTEP 3: Add or Substitute with one of
Prescribing of Hypoglycaemic Agents for Adult Patients with Type 2 Diabetes: Sunderland Refer to DESMOND Structured Education classes to promote Increased Physical Activity, Weight Loss and Calories Reduction
More informationThis program applies to Commercial, GenPlus and Health Insurance Marketplace formularies.
OBJECTIVE The intent of the GLP-1 (glucagon-like peptide-1) Agonists [Adlyxin (lixisenatide), Byetta (exenatide), Bydureon (exenatide extended-release), Tanzeum (albiglutide), Trulicity (dulaglutide),
More informationGlucose Control drug treatments
Glucose Control drug treatments It should be noted that glitazones are under suspicion of precipitating acute cardiac events and current recommendations contraindicate the use of glitazones in patients
More informationManagement of Women with Type I Diabetes or Insulin Treated Type II Diabetes
Management of Women with Type I Diabetes or Insulin Treated Type II Diabetes Author: Women & Child Health Specialty: Labour Ward Forum Date Approved: March 2017 Approved by: W&CH Clinical Governance Committee
More informationSCHOOL HEALTH PLAN: DIABETES
BRANDON FLORENCE MCLAURIN NORTHWEST PELAHATCHIE RANKIN COUNTY SCHOOL DISTRICT GREAT TO BEST PISGAH PUCKETT RICHLAND RANKIN COUNTY SCHOOL DISTRICT SCHOOL HEALTH PLAN: DIABETES of Plan: Effective s: This
More informationNorthumbria Healthcare NHS Foundation Trust. Sick Day Rules for People with Diabetes. Issued by the Diabetes Service
Northumbria Healthcare NHS Foundation Trust Sick Day Rules for People with Diabetes Issued by the Diabetes Service www.northumbria.nhs.uk Background: How illness may affect your diabetes 3 What to do for
More informationArrange 3 Monthly Review Re-enforce LIFESTYLE advice and check DRUG COMPLIANCE at each visit Target HbA1c < 53mmol/mol
Prescribing of Hypoglycaemic Agents for Adult Patients with Type 2 Diabetes: Sunderland Refer to DESMOND Structured Education classes to promote Increased Physical Activity, Weight Loss and Calories Reduction
More informationManagement of Type 2 Diabetes
Management of Type 2 Diabetes Pathophysiology Insulin resistance and relative insulin deficiency/ defective secretion Not immune mediated No evidence of β cell destruction Increased risk with age, obesity
More informationDiabetes Newly Diagnosed with NO evidence of DKA
1. DIAGNOSIS confirmed by doctor using below guidelines: (a) History of Polyuria (usually nocturia ± enuresis) Polydipsia. ± Weight Loss (b) Glycosuria (c) Blood Glucose (BG) > 11 mmol/l (confirm from
More informationINSULIN 101: When, How and What
INSULIN 101: When, How and What Alice YY Cheng @AliceYYCheng Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form
More informationTABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations
177 TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations Formulary
More informationMedical care of diabetes - what s new?
emedic research training 29 May 2012 Loimaa Medical care of diabetes - what s new? Markku Vähätalo Specialist in General Practice Special qualification for the treatment of diabetes Loimaa health centre
More informationSelf-Monitoring Blood Glucose (SMBG) Frequency & Pattern Tool
Self-Monitoring Blood Glucose () Pattern Recommendation: Basal Insulin Only (To Target) NPH or long-acting analogue, typically given at. at least as often as is being given. Optional, less frequent can
More informationThe Wheel of Life Exercise. What s Happening? Where to start the beginning. What's in a meter- are they all the same?
Wharfedale Hospital Otley Linda Clapham BSc Hons. RGN, SEN,Cert. Ed. The Wheel of Life Exercise An exercise to Encourage self management Work What s going on! Medication Helping patients succeed Diabetes
More informationThe New Age of Insulin: Exploring the Latest Trends in Insulin Therapy. The New Age of Insulin: Exploring the Latest Trends in Insulin Therapy
The New Age of Insulin: Exploring the Latest Trends in Insulin Therapy Susan Cornell, PharmD, CDE, FAPhA, FAADE Associate Director of Experiential Education Associate Professor of Pharmacy Practice Midwestern
More informationA Fact Sheet for Parents and Carers Insulin and Diabetes
A Fact Sheet for Parents and Carers Insulin and Diabetes In type 1 diabetes the body stops producing insulin. Insulin therapy is essential in the treatment of type 1 diabetes, together with a healthy eating
More informationDiabetes Medical Management Plan
of Plan: School year: Diabetes Medical Management Plan This plan should be completed by the student s personal health care team and parents/guardian. It should be reviewed with relevant school staff and
More informationManagement of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines. Diabetes Inpatient Steering Group June 2016
Management of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines Diabetes Inpatient Steering Group June 2016 1. Introduction 1.1 The aim of the guideline is to improve standards
More informationBeyond A1C. Non-glycemic Effects of GLP-1 Receptor Agonists. Olga Astapova MD, PhD Luis Chavez MD URMC Endocrinology Fellows
Beyond A1C Non-glycemic Effects of GLP-1 Receptor Agonists Olga Astapova MD, PhD Luis Chavez MD URMC Endocrinology Fellows Disclosures No conflicts of interest. Learning Objectives 1. Understand the physiological
More informationManaging Special Circumstances Key Points
Managing Special Circumstances Key Points Hypoglycaemia Dr Arla Ogilvie Diabetes Consultant (Watford) Sick Day Rules Janet Guest Community DSN (Hertford) Preparing for Colonoscopy Carolyn Jones In-Patient
More informationNewer Insulins. Boca Raton Regional Hospital 15th Annual Internal Medicine Conference
Newer Insulins Boca Raton Regional Hospital 15th Annual Internal Medicine Conference Luigi F. Meneghini, MD, MBA Professor of Internal Medicine, UT Southwestern Medical Center Executive Director, Global
More informationLet s not sugarcoat it! Update on Pharmacologic Management of Type II DM
Let s not sugarcoat it! Update on Pharmacologic Management of Type II DM Gregory Castelli, PharmD, BCPS, BC-ADM Clinical Pharmacist UPMC St. Margaret Objectives By the end of this presentation, participants
More informationPharmacological Glycaemic Control in Type 2 Diabetes
Pharmacological Glycaemic Control in Type 2 Diabetes Aim(s) and Objective(s) This guideline aims to offer advice on the pharmacological management for those who require measures beyond diet and exercise
More informationGLUCAGON LIKE PEPTIDE (GLP) 1 AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES, WEIGHT CONTROL AND CARDIOVASCULAR PROTECTION.
GLUCAGON LIKE PEPTIDE (GLP) 1 AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES, WEIGHT CONTROL AND CARDIOVASCULAR PROTECTION. Patricia Garnica MS, ANP-BC, CDE, CDTC Inpatient Diabetes Nurse Practitioner North
More informationProcedure for the prescribing and administration of insulin
Procedure for the prescribing and administration of insulin Author: Lilian Baxendale and Heather Beadle Designation: Clinical Governance Pharmacists Version: Version 3 Date: December 2016 Date Approved:
More informationStaying safe on an insulin pump
Staying safe on an insulin pump Exceptional healthcare, personally delivered Insulin pump therapy is a safe and effective way of treating diabetes. However due to the way the insulin is delivered, problems
More informationRDNS. Injection Therapy in injection therapy in diabetes. Type 2 Diabetes
RDNS Injection Therapy in injection therapy in diabetes Type 2 Diabetes Australian Diabetes Society (ADS) HbA1c targets for T2DM Specific Clinical Situations HbA1c General 7% Diabetes of short duration
More informationClinical Support Guide Injectable treatments for adults with diabetes
Clinical Support Guide Injectable treatments for adults with diabetes Developed by: CHSALHN Diabetes Service Approved by: CHSALHN, Clinical Governance Committee on: 05/12/2018 Next review due: 05/12/2021
More information667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY
667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY Contents Introduction... 1 Patient Education for People with Type 2 Diabetes... 2 Dietary Advice for People with Type 2 Diabetes...
More informationDiabetes Medical Management Plan
Diabetes Medical Management Plan 1 School District: School: School Year: Grade: Student Name: DOB: Provider Name: Phone #: Fax #: Blood Glucose Monitoring at School Blood Glucose Target Range: - mg/dl
More information3. Cardiovascular Disease?
Swiss recommendations 2016 Swiss Society of Endocrinology and Diabetology 1. Deficiency? Basal Premixed- Basal + GLP-1 RA (Xultophy ) or Basal Bolus 2. egfr < 30 ml/min? 3. Cardiovascular Disease? 4. Heart
More informationThe first stop for professional medicines advice
London Medicines Evaluation Network Overview: Glucagon-Like Peptide-1 receptor analogues The first stop for professional medicines advice 1 London Medicines Evaluation Network Overview: Glucagon-Like Peptide-1
More informationDiabetes Medical Management Plan
SCHOOL DISTRICT OF LEE COUNTY HEALTH SERVICES Print Form Date of Plan Diabetes Medical Management Plan This plan should be completed by the student's personal health care team and parents/guardian. It
More informationWhat s New in Type 2 Diabetes? 2018 Diabetes Updates
What s New in Type 2 Diabetes? 2018 Diabetes Updates Gretchen Ray, PharmD, PhC, BCACP, CDE Associate Professor, UNM College of Pharmacy January 28, 2018 gray@salud.unm.edu OBJECTIVES Describe the most
More information